Annaul Report for FY 2024-25 as per Reg. 34 of SEBI LODR, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amkay Products Limited has submitted its 18th Annual Report for FY 2024-25 along with the notice for the 18th AGM, scheduled to be held on Monday, September 29, 2025 at 12:00 PM via Video Conferencing. Revenue from operations grew to Rs. 3,839.01 lakh in FY25 from Rs. 3,106.91 lakh in FY24, an increase of about 23.6%. Profit After Tax rose to Rs. 333.85 lakh from Rs. 263.00 lakh, a growth of around 27%. The company manufactures medical devices and healthcare products such as face masks, alcohol swabs, lancet needles, nebulizers, BP monitors, thermometers, and hot water bags from its two units in Palghar, Thane. Key agenda items include re-appointment of Mr. Hemanshu Kantilal Batavia (Whole-time Director & CFO) by rotation and appointment of M/s. Pimple & Associates as Secretarial Auditor for a five-year term (FY 2025-26 to 2029-30). The company had recently listed on BSE SME platform in May 2024 following a successful IPO of 22,92,000 equity shares.
Steady revenue and profit growth in the first full year post-IPO signals healthy business momentum, likely to be viewed positively by shareholders. No dividend or major capital action proposed in the AGM agenda beyond routine re-appointments and auditor change.